The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

The move comes after Robert F. Kennedy Jr. received pressure from the Children’s Health Defense, an anti-vaccine non-profit ...

As Trump has pressured drugmakers to lower the cost of medicines in the U.S., the pharma industry has coalesced behind a ...

The Boston-based AI/ML startup focuses on endocrine and cardiometabolic diseases and will use that expertise to generate new ...

WARN notices provide a heads up that staff will soon be unemployed, but the act that mandates them has some nuances. An ...

The HHS secretary recently canceled $500 million worth of BARDA contracts around mRNA vaccine research. But the U.S.

The death was linked to acute kidney injury in a patient who had a single kidney remaining and a “complex medical history,” ...

Citing other priorities—such as the upcoming U.S.-Russia summit—four anonymous sources claim that pharma tariffs could still ...

After two patients who received the investigational CDC7 blocker died, pushing forward with SGR-2921’s development would be ...

Vedanta is parting ways with 23 employees, or approximately 20% of its headcount, after Phase II data for microbiome therapy ...

In this episode of Denatured, BioSpace’s head of insights Lori Ellis discusses the ‘enormous implications’ of patent policy ...

In May 2025, the White House announced a ‘Most Favored Nation’ approach for setting prescription drug prices. The order aims ...